Contribution: Industrial Research Assistance Program – Contributions to Firms
Microbix Biosystems Inc.
$249,500.00
Rubella BR2s Downstream Process Streamlining
FY 2018-19 · 2018-09-03
Summary
Microbix has recently increased its production capacity of Rubella product and reduced manufacturing costs by developing and implementing a new, automated bioreactor production platform for production of Rubella virus, its largest and fasted growing product line. Customers around the world, have provided good feedback and have begun transition of their regulated medical devices to use Microbix’ bioreactor product. As a consequence of this customer demand, Microbix will initiate a new project to debottleneck and streamline the purification process: to reduce process steps, increase step automation and to introduce new process control test methodologies.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Mississauga|Mississauga, Ontario, Canada
Recipient Type
For-profit organization
Business Number
103676466
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-09-03 | 2018-19 | $249,500.00 |
| 2 | 2018-09-03 | 2018-19 | $249,500.00 |
| 3 | 2018-09-03 | 2018-19 | $249,500.00 |
| 4 | 2018-09-03 | 2018-19 | $249,500.00 |
| 5 | 2018-09-03 | 2018-19 | $249,500.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 151 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 151 jours.
Agreement End Date
2022-02-28
Agreement Number
914177
Agreement Start Date
2018-09-03
Agreement Title
Rubella BR2s Downstream Process Streamlining
Agreement Title (French)
Rationalisation des processus en aval de rubéole BR2
Agreement Type
Contribution
Agreement Value
$249,500.00
Amendment Date
2021-09-12
Amendment Number
5
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Microbix has recently increased its production capacity of Rubella product and reduced manufacturing costs by developing and implementing a new, automated bioreactor production platform for production of Rubella virus, its largest and fasted growing product line. Customers around the world, have provided good feedback and have begun transition of their regulated medical devices to use Microbix’ bioreactor product. As a consequence of this customer demand, Microbix will initiate a new project to debottleneck and streamline the purification process: to reduce process steps, increase step automation and to introduce new process control test methodologies.
Description (French)
Microbix a récemment augmenté sa capacité de production de rubéole et réduit ses coûts de fabrication en développant et en implémentant une nouvelle plate-forme de production de bioréacteurs automatisée pour la production du virus de la rubéole, sa gamme de produits la plus importante et à croissance rapide. Des clients du monde entier ont fourni de bons retours d’information et ont commencé la transition de leurs dispositifs médicaux réglementés vers l’utilisation du bioréacteur Microbix. En conséquence de cette demande client, Microbix lancera un nouveau projet visant à débloquer et à rationaliser le processus de purification : réduire le nombre d'étapes du processus, augmenter l'automatisation des étapes et introduire de nouvelles méthodologies de test de contrôle du processus.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Mississauga--Malton
Federal Riding (French)
Mississauga--Malton
Federal Riding Number
35062
NAICS Code
325410
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
103676466
Recipient City
Mississauga|Mississauga
Recipient Country
CA
Recipient Legal Name
Microbix Biosystems Inc.
Recipient Postal Code
L4Z 1P3
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2018-2019-Q3-914177
